scholarly article | Q13442814 |
P356 | DOI | 10.1007/3-211-30714-1_29 |
P698 | PubMed publication ID | 16671440 |
P2093 | author name string | T Maeda | |
T Mori | |||
Y Katayama | |||
T Kawamata | |||
Y Shigemori | |||
P921 | main subject | blood–brain barrier | Q221694 |
P304 | page(s) | 130-133 | |
P577 | publication date | 2006-01-01 | |
P1433 | published in | Acta Neurochirurgica. Supplementum | Q15750154 |
P1476 | title | Matrix metalloproteinase-9 is associated with blood-brain barrier opening and brain edema formation after cortical contusion in rats | |
P478 | volume | 96 |
Q34422275 | Ablation of matrix metalloproteinase-9 gene decreases cerebrovascular permeability and fibrinogen deposition post traumatic brain injury in mice |
Q90098730 | Assessment of recombinant tissue plasminogen activator (rtPA) toxicity in cultured neural cells and subsequent treatment with poly-arginine peptide R18D |
Q35146718 | Association between serum tissue inhibitor of matrix metalloproteinase-1 levels and mortality in patients with severe brain trauma injury. |
Q89612190 | Basic Fibroblast Growth Factor (bFGF) Protects the Blood-Brain Barrier by Binding of FGFR1 and Activating the ERK Signaling Pathway After Intra-Abdominal Hypertension and Traumatic Brain Injury |
Q87870397 | Blood brain barrier (BBB)-disruption in intracortical silicon microelectrode implants |
Q48382130 | Blood-brain barrier permeability is positively correlated with cerebral microvascular perfusion in the early fluid percussion-injured brain of the rat. |
Q38196884 | Cell-specific blood-brain barrier regulation in health and disease: a focus on hypoxia |
Q38826051 | Chloride Dysregulation, Seizures, and Cerebral Edema: A Relationship with Therapeutic Potential |
Q37730929 | Colibactin Contributes to the Hypervirulence of pks+ K1 CC23 Klebsiella pneumoniae in Mouse Meningitis Infections. |
Q30985506 | Dietary Docosahexaenoic Acid Improves Cognitive Function, Tissue Sparing, and Magnetic Resonance Imaging Indices of Edema and White Matter Injury in the Immature Rat after Traumatic Brain Injury |
Q46492590 | Early to Long-Term Alterations of CNS Barriers After Traumatic Brain Injury: Considerations for Drug Development. |
Q33702239 | Effects of aging on blood brain barrier and matrix metalloproteases following controlled cortical impact in mice. |
Q33553427 | Efficacy of a metalloproteinase inhibitor in spinal cord injured dogs |
Q37393237 | Elevation of matrix metalloproteinases 3 and 9 in cerebrospinal fluid and blood in patients with severe traumatic brain injury |
Q47407286 | Exposure to traffic-generated air pollutants mediates alterations in brain microvascular integrity in wildtype mice on a high-fat diet |
Q64230027 | FGF21 Protects Against Hypoxia Injury Through Inducing HSP72 in Cerebral Microvascular Endothelial Cells |
Q30570065 | Fish oil improves motor function, limits blood-brain barrier disruption, and reduces Mmp9 gene expression in a rat model of juvenile traumatic brain injury |
Q28972580 | Fixed negative charge and the Donnan effect: a description of the driving forces associated with brain tissue swelling and oedema |
Q36750801 | Fluorometric immunocapture assay for the specific measurement of matrix metalloproteinase-9 activity in biological samples: application to brain and plasma from rats with ischemic stroke |
Q53074197 | Glibenclamide produces region-dependent effects on cerebral edema in a combined injury model of traumatic brain injury and hemorrhagic shock in mice. |
Q40111896 | Immortalized human brain endothelial cells and flow-based vascular modeling: a marriage of convenience for rational neurovascular studies |
Q26766038 | Implications of MMP9 for Blood Brain Barrier Disruption and Hemorrhagic Transformation Following Ischemic Stroke |
Q38612271 | Inhibition of acetylcholinesterase modulates NMDA receptor antagonist mediated alterations in the developing brain |
Q47851530 | Inhibition of mTOR protects the blood-brain barrier in models of Alzheimer's disease and vascular cognitive impairment |
Q61796951 | Japanese encephalitis virus neuropenetrance is driven by mast cell chymase |
Q36079895 | MT5-MMP, ADAM-10, and N-cadherin act in concert to facilitate synapse reorganization after traumatic brain injury |
Q36123018 | Matrix Metalloproteinase Expression in Contusional Traumatic Brain Injury: A Paired Microdialysis Study |
Q41230899 | Matrix metalloproteinase inhibition reduces oxidative stress associated with cerebral amyloid angiopathy in vivo in transgenic mice |
Q36761698 | Matrix metalloproteinase-9 deficiency leads to prolonged foreign body response in the brain associated with increased IL-1beta levels and leakage of the blood-brain barrier |
Q48111112 | Matrix metalloproteinases 2 and 9 fail to influence drug-induced neuroapoptosis in developing rat brain |
Q37733211 | Matrix metalloproteinases and neurotrauma: evolving roles in injury and reparative processes |
Q49827436 | Mechanical disruption of the blood-brain barrier following experimental concussion |
Q40112481 | Moderate and severe traumatic brain injury induce early overexpression of systemic and brain gelatinases |
Q48113339 | Neuroimmunology of Traumatic Brain Injury: Time for a Paradigm Shift |
Q57811980 | Neuroinflammation, oxidative stress, and blood-brain barrier (BBB) disruption in acute Utah electrode array implants and the effect of deferoxamine as an iron chelator on acute foreign body response |
Q33657719 | Neuroprotective effects of overexpressing tissue inhibitor of metalloproteinase TIMP-1. |
Q26768672 | New Prognostic Biomarkers in Patients With Traumatic Brain Injury |
Q47787773 | Oxidative stress in drug-naïve first episode patients with schizophrenia and major depression: effects of disease acuity and potential confounders. |
Q38459572 | Pathogenesis of brain edema and investigation into anti-edema drugs |
Q57170806 | Pathophysiology and treatment of cerebral edema in traumatic brain injury |
Q39008879 | Peptide Pharmacological Approaches to Treating Traumatic Brain Injury: a Case for Arginine-Rich Peptides |
Q41413177 | Pharmacological targeting of β-adrenergic receptor functions abrogates NF-κB signaling and MMP-9 secretion in medulloblastoma cells |
Q35589875 | Preservation of the blood brain barrier and cortical neuronal tissue by liraglutide, a long acting glucagon-like-1 analogue, after experimental traumatic brain injury |
Q34489690 | Resveratrol neuroprotection in stroke and traumatic CNS injury |
Q35007289 | Reversal of West Nile virus-induced blood-brain barrier disruption and tight junction proteins degradation by matrix metalloproteinases inhibitor |
Q38626384 | Role of Matrix Metalloproteinases in the Pathogenesis of Traumatic Brain Injury |
Q54977421 | Selective Toll-Like Receptor 4 Antagonists Prevent Acute Blood-Brain Barrier Disruption After Subarachnoid Hemorrhage in Mice. |
Q44246688 | Single nucleotide polymorphisms in the angiogenic and lymphangiogenic pathways are associated with lymphedema caused by Wuchereria bancrofti |
Q48429410 | Sulfonylurea Receptor-1: A Novel Biomarker for Cerebral Edema in Severe Traumatic Brain Injury |
Q59807366 | Sulforaphane from Cruciferous Vegetables: Recent Advances to Improve Glioblastoma Treatment |
Q37692206 | The Immunomodulatory Effects of Plant Extracts and Plant Secondary Metabolites on Chronic Neuroinflammation and Cognitive Aging: A Mechanistic and Empirical Review |
Q90070819 | The Medical Management of Cerebral Edema: Past, Present, and Future Therapies |
Q37154481 | The potential utility of blood-derived biochemical markers as indicators of early clinical trends following severe traumatic brain injury |
Q33699683 | Tobacco smoke: a critical etiological factor for vascular impairment at the blood-brain barrier |
Q33649452 | Traumatic brain injury results in disparate regions of chondroitin sulfate proteoglycan expression that are temporally limited |
Search more.